Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension

Physiol Res. 1996;45(4):317-21.

Abstract

The responsiveness of isolated high-pressure (aorta, renal artery) and low-pressure vessels (pulmonary artery) was compared during systemic hypertension induced by chronic inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME) in rats. L-NAME (40 mg/kg/day) was given to animals in their drinking water. After 4 weeks of L-NAME treatment, systolic blood pressure increased by 37% as compared with that in the control group. Chronic L-NAME treatment resulted in significant reduction of endothelium-dependent relaxation to acetylcholine (10(-8) to 3 x 10(-6) mol/l) in both types of vessels. The reduced relaxation was not influenced by acute pretreatment with indomethacin (10(-5) mol/l), however, it was further reduced by acute pretreatment with additional L-NAME (10(-4) mol/l). L-arginine (10(-4) mol/l) improved the reduced relaxation. Endothelium-independent relaxation to sodium nitroprusside (10(-9) to 10(-6) mol/l) was unaffected by L-NAME treatment. beta-adrenoceptor-mediated relaxation to isoprenaline (10(-8) to 3 x 10(-6) mol/l) was also not influenced by chronic L-NAME treatment. Similar alterations in the responsiveness of high- and low-pressure vessels indicate rather the decisive role of nitric oxide restriction than that of elevated blood pressure in their development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Adrenergic alpha-Agonists / pharmacology
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Aorta / drug effects
  • Aorta / physiology
  • Cyclooxygenase Inhibitors / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Hypertension / metabolism
  • Hypertension / physiopathology*
  • Indomethacin / pharmacology
  • Isoproterenol / pharmacology
  • Male
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism*
  • Norepinephrine / pharmacology
  • Pulmonary Circulation / physiology
  • Rats
  • Rats, Wistar
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • Adrenergic alpha-Agonists
  • Adrenergic beta-Agonists
  • Cyclooxygenase Inhibitors
  • Enzyme Inhibitors
  • Nitric Oxide
  • Isoproterenol
  • Acetylcholine
  • NG-Nitroarginine Methyl Ester
  • Norepinephrine
  • Indomethacin